---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-187014"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2022-07-01T23:59:59+00:00"
generated_at: "2026-06-24T21:52:01.441776+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ResMed promotes Lucile Blaise to President of Sleep & Respiratory Care effective July 1

## Summary
- Lucile Blaise, previously VP of Sleep & Respiratory Care for Western Europe, promoted to President of global Sleep & Respiratory Care, effective July 1, 2022.
- Blaise has over 25 years in medtech, including 16 years at ResMed; elected President of Snitem in June 2022 and serves on MedTech Europe board.
- Compensation: annual base salary $470,000, target STI 80%, equity target $1,400,000, plus relocation benefits for move to U.S.
- Robert Douglas will cease as interim President of the business but remains President and COO of ResMed.

## SEC filing metadata
- accession: 0001193125-22-187014
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2022-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/0001193125-22-187014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/d360618d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-187014
- JSON: https://secwatch.observer/filing/0001193125-22-187014.json
- Plain text: https://secwatch.observer/filing/0001193125-22-187014.txt

## Key facts
- Executive change
  Robert Douglas changed role as Interim President, Sleep and Respiratory Care at RESMED INC.
  - Action: ceased interim role
  - Role: Interim President, Sleep and Respiratory Care
  source text: Concurrent with Ms. Blaise’s July 1, 2022 appointment, Robert Douglas will no longer serve as our interim president, sleep and respiratory care business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/0001193125-22-187014-index.htm
- Executive change
  Lucile Blaise was appointed as President, Sleep and Respiratory Care at RESMED INC.
  - Action: promoted
  - Role: President, Sleep and Respiratory Care
  source text: On June 28, 2022, we announced that we are promoting Lucile Blaise, age 51, to serve as our president, sleep and respiratory care business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/0001193125-22-187014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.